Medical Frontiers

$China Breaks the Deadlock of the "Immortal Cancer": CAR-NK Therapy Published in The Lancet, Bringing New Hope for a Cure for Refractory Systemic Lupus Erythematosus$

China Breaks the Deadlock of the "Immortal Cancer": CAR-NK Therapy Published in The Lancet, Bringing New Hope for a Cure for Refractory Systemic Lupus Erythematosus

2026-04-30

On November 13, 2025, The Lancet, the world's top medical journal, published a landmark research result by the team of Professors Zhao Dongbao and Gao Jie from the First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital) as an original article—the world's first systemic application of off-the-shelf CD19 CAR-NK cell therapy (KN5501) in the treatment of refractory systemic lupus erythematosus (SLE)

MORE DETAILS

World's First Invasive Brain-Computer Interface Class III Medical Device Wins Market Approval in China

2026-04-30

SHANGHAI, March 13, 2026 — China's National Medical Products Administration (NMPA) has granted market approval for the world's first invasive brain-computer interface (BCI) Class III medical device, a landmark milestone that moves the transformative neurotechnology from laboratory research to standardized large-scale clinical use globally.

MORE DETAILS

World's First! China Achieves Functional Cure of Early-Onset Parkinson's Disease with Stem Cell Therapy, Rewriting the Treatment Landscape of Neurodegenerative Diseases

2026-04-30

MORE DETAILS